Cholera: Immunity and Prospects in Vaccine Development

Area of Science:

• Infectious Diseases
• Immunology
• Vaccinology

Background:

• Vibrio cholerae causes cholera, a significant public health threat.
• Immunity after infection or vaccination is linked to vibriocidal antibodies, but these may be surrogate markers for mucosal immunity.
• Current oral cholera vaccines have limited efficacy in young children.

Purpose of the Study:

• To review the immune responses to Vibrio cholerae infection and vaccination.
• To discuss the limitations of current cholera vaccines.
• To explore future cholera vaccine development strategies.

Main Methods:

• Review of existing literature on cholera pathogenesis, immunity, and vaccination.
• Analysis of correlates of protection against cholera.
• Discussion of emerging vaccine technologies.

Main Results:

• Long-lasting protection against cholera follows infection, mediated by immune responses targeting the O-polysaccharide antigen.
• Vibriocidal antibody responses are correlates of protection but may not fully represent mucosal immunity.
• Current whole-cell oral vaccines show reduced efficacy in young children.

Conclusions:

• Development of novel cholera vaccines, including conjugate and live attenuated vaccines, is crucial.
• Multivalent vaccines targeting cholera and other enteric infections are desirable for integration into standard immunization schedules.
• Improving vaccine efficacy in vulnerable populations, particularly young children, remains a key objective.